Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
8

Summary

Conditions
Sars Cov 2
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Basic Science

Participation Requirements

Age
Younger than 125 years
Gender
Both males and females

Description

In December 2019, a new coronavirus causing severe acute respiratory syndrome was described in Wuhan, China. This virus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread worldwide and has been designated a pandemic by the World Health Organization. By the beginning of...

In December 2019, a new coronavirus causing severe acute respiratory syndrome was described in Wuhan, China. This virus, later named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), spread worldwide and has been designated a pandemic by the World Health Organization. By the beginning of March 2020, several Ear, Nose, Throat societies raised awareness of a frequent association between coronavirus disease 2019 (COVID-19) and smell disorders. In the present study, the investigators wish to begin to understand the pathogenesis of olfactory dysfunction in COVID-19.

Tracking Information

NCT #
NCT04445597
Collaborators
  • Max Planck Research Unit for Neurogenetics
  • AZ Sint-Jan Brugge-Oostende AV
  • Hospital Clinic of Barcelona
  • Centro Hospitalar Lisboa Norte
Investigators
Principal Investigator: Laura Van Gerven UZ/KU Leuven